8th Oncolytic Virotherapy Summit 2023

Conference themes
Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies

Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy.

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/1948756-3?pid=4832

Speakers: Angelica Loskog | Chief Executive Officer | Lokon Pharma AB, Antonio Santidrian | Global Head of R and D | Calidi Biotherapeutics Inc., and more

https://go.evvnt.com/1948756-2?pid=4832

Ms. Phoebe Morris